Regulation of E-cadherin/catenin association by tyrosine phosphorylation.

  title={Regulation of E-cadherin/catenin association by tyrosine phosphorylation.},
  author={Santiago Roura and Susana Miravet and José A. Piedra and Antonio Garc{\'i}a de Herreros and Mireia Du{\~n}ach},
  journal={The Journal of Biological Chemistry},
  pages={18853 - 18853}
Santiago Roura, Susana Miravet, José Piedra, Antonio Garcı́a de Herreros, and Mireia Duñach Several concerns were raised about Figs. 3, 4, and 5 by the journal. Because the original data were no longer available, the experiments shown in these figures were repeated. The repeated experiments are shown and do not affect the results or conclusions of this work. The authors regret the inconvenience these errors may have produced. 

Figures from this paper

Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1
Nek2 phosphorylates the same regulatory sites (S33/S37/T41) as GSK3β in β-catenin, as well as additional sites, and inhibits binding of the E3 ligase β-TrCP to β-catsin, thereby preventing β- catenin ubiquitination and degradation.
Phosphoregulation of the C. elegans cadherin-catenin complex.
These findings support a model in which distinct phosphorylation events contribute to rapid CCC assembly and disassembly, both of which are essential for morphogenetic rearrangements during development.
Muc 4 Modulation of Ligand-Independent ErbB 2 Signaling
The results suggest that Muc4 is a potent oncogenic factor, and further enhance the understanding of the role that MUC4 plays in ligand-independent intracellular signaling.
4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines
The membrane-cytoskeletal protein 4.1N was shown to directly interact with the lipid raft marker flotillin-1 through its FERM and U2 domains in several different NSCLC cell lines using immunoprecipitation, co-immunop Recipitation and pull-down assays to elucidate the novel tumor suppressor role of 4.
Hepatocyte Growth Factor modulates MET receptor tyrosine kinase and #-catenin functional interactions to enhance synapse formation MET signaling in synapse formation
Hepatocyte Growth Factor modulates MET receptor tyrosine kinase and #-catenin functional interactions to enhance synapse formation MET signaling in synapse formation Zhihui Xie, Kathie L. Eagleson,
Inhibition of E-cadherin/catenin complex formation by O-linked N-acetylglucosamine transferase is partially independent of its catalytic activity.
A novel underlying mechanism of the regulation of the interaction between p120 and E‐cadherin is provided, and thus E‑cadhersin‑mediated cell‑cell adhesion, which has essential roles in cancer development and progression is provided.
Adherens Junction and E-Cadherin complex regulation by epithelial polarity
It is proposed that by regulating key phosphorylation events on the core E-Cadherin complex components, Par3 and epithelial polarity promote meta-stable protein complexes governing the correct formation, localization, and functioning of AJ.
HER2 activation results in β-catenin-dependent changes in pulmonary epithelial permeability.
  • J. Finigan, V. Vasu, J. Kern
  • Biology, Medicine
    American journal of physiology. Lung cellular and molecular physiology
  • 2015
The data indicate that HER2 interacts with β-catenin, leading to dissolution of the AJ, decreased cell-cell adhesion, and disruption of the pulmonary epithelial barrier.
Src- and confinement-dependent FAK activation causes E-cadherin relaxation and β-catenin activity
E-cadherin acts as a sensor of intracellular mechanics in a crosstalk with cell-substrate adhesions that target &bgr;-catenin signaling, and it is demonstrated that nuclear activity following a substantial release from the membrane specific to migrating cells and requires multicellular deconfinement and Src activity.
β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis.
  • S. Monga
  • Biology, Medicine
  • 2015
How alterations in β-catenin activity contribute to liver disease and how these might be used in diagnosis and prognosis, as well as in the development of therapeutics are discussed.